Following publication of the original article [1], the authors noticed that Fig. 4 was a duplicate of Fig. 3. This correction article consists of the correct Fig. 3 and Fig. 4. The original article [1] has been corrected.
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis / Cirillo, Alessio; Marinelli, Daniele; Romeo, Umberto; Messineo, Daniela; De Felice, Francesca; De Vincentiis, Marco; Valentini, Valentino; Mezi, Silvia; Valentini, Filippo; Vivona, Luca; Chiavassa, Antonella; Cerbelli, Bruna; Santini, Daniele; Bossi, Paolo; Polimeni, Antonella; Marchetti, Paolo; Botticelli, Andrea. - In: BMC CANCER. - ISSN 1471-2407. - 24:1(2024), pp. 1-2. [10.1186/s12885-024-12249-y]
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis
Cirillo, AlessioPrimo
;Marinelli, Daniele
Secondo
;Romeo, Umberto;Messineo, Daniela;De Felice, Francesca;De Vincentiis, Marco;Valentini, Valentino;Mezi, Silvia;Vivona, Luca;Chiavassa, Antonella;Cerbelli, Bruna;Santini, Daniele;Bossi, Paolo;Polimeni, Antonella;Marchetti, PaoloPenultimo
;Botticelli, AndreaUltimo
2024
Abstract
Following publication of the original article [1], the authors noticed that Fig. 4 was a duplicate of Fig. 3. This correction article consists of the correct Fig. 3 and Fig. 4. The original article [1] has been corrected.| File | Dimensione | Formato | |
|---|---|---|---|
|
Cirillo_Correction: Pembrolizumab_2024.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
899.3 kB
Formato
Adobe PDF
|
899.3 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
